Prior Auth Required

20930 - does not require prior authorization. Effective 4/1/2024

This procedure appears on the selected insurer prior authorization source.

Check another codeExplore policy data
Prior authorizationPrior Auth Required
Procedure / Servicedoes not require prior authorization. Effective 4/1/2024
Procedure / Service Description

4/2024 MP 097 Bone Morphogenetic Protein. Prior authorization requirements removed. CPT - 15832, 15833, 15834, 15835, 15836, 15878, 15879. Effective 5/1/2024. 4/2024 MP 097 Bone Morphogenetic Protein. Prior authorization requirements removed. CPT 20930 does not require prior authorization. Effective 4/1/2024. MP 028 Omidubicel as Adjunct Treatment for Hematologic Malignancies. Policy revised to

Likely documents
  • Confirm benefit details
  • Submit clinical notes if requested by the plan
Next actions
  • Confirm the current plan policy before submission.
  • Use the insurer authorization workflow for this listed code.